Megan D. Hoban
Forma Therapeutics (United States)(US)C4 Therapeutics (United States)(US)Casma Therapeutics (United States)(US)
Publications by Year
Research Areas
CRISPR and Genetic Engineering, Virus-based gene therapy research, CAR-T cell therapy research, RNA Interference and Gene Delivery, Hemoglobinopathies and Related Disorders
Most-Cited Works
- → Analyzing CRISPR genome-editing experiments with CRISPResso(2016)488 cited
- → Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells(2015)318 cited
- → CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells(2016)214 cited
- → Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease(2016)180 cited
- → Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome(2018)138 cited
- → Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates(2019)123 cited
- →